Oral Antiviral Drug Effective Against Respiratory Syncytial Virus (RSV) Identified by Biomedical Sciences Researchers
Oral Antiviral Drug Effective Against Respiratory Syncytial Virus (RSV) Identified by Biomedical Sciences Researchers
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.